RT @JulesBauer0: La primaquine 🔴💊🦟 #IDtwitter #worldmalariaday #MedEd Références : 💊 OMS 2016 : https://t.co/pydjoB96QW 💊 Cochrane 2019 :…
La primaquine 🔴💊🦟 #IDtwitter #worldmalariaday #MedEd Références : 💊 OMS 2016 : https://t.co/pydjoB96QW 💊 Cochrane 2019 : https://t.co/PWbPvG7V5U 💊 Lancet 2019 : https://t.co/MbYm8EBDfE https://t.co/vJlDvDdJEc
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax - Milligan, R - 2020 | Cochrane Library https://t.co/om0KhlU06G
RT @epivec: @CochraneLibrary reviews never meant to be the final word, just a contribution to the debate. Summary of where we are, what com…
RT @ricprice99: Latest Cochrane review on optimal dose of primaquine for #vivax radical cure. Useful insights, but avoids the elephant in t…
@CochraneLibrary reviews never meant to be the final word, just a contribution to the debate. Summary of where we are, what comparisons are important, and combining diverse outcomes. Was important to update more quickly than usual to include IMPROV and Chu
RT @ricprice99: Latest Cochrane review on optimal dose of primaquine for #vivax radical cure. Useful insights, but avoids the elephant in t…
Thank you @ricprice99 and team for your massive contributions to this topic and evidence
Agree, but can only review the trials that are done, where they are done, and the #G6PD replete people that are included in them. Look forward to more info. @Cochrane_IDG
Latest Cochrane review on optimal dose of primaquine for #vivax radical cure. Useful insights, but avoids the elephant in the room... that the safety and efficacy pf of PQ (and thus comparison between regimens) varies with location and host population http
RT @epivec: #Primaquine for preventing #Plasmodium #vivax relapses @jcu @AITropHealthMed @CPHMVS_JCU @WHOSEARO @WHOWPRO https://t.co/TdHDwx…
RT @epivec: #Primaquine for preventing #Plasmodium #vivax relapses @jcu @AITropHealthMed @CPHMVS_JCU @WHOSEARO @WHOWPRO
RT @epivec: #Primaquine for preventing #Plasmodium #vivax relapses @jcu @AITropHealthMed @CPHMVS_JCU @WHOSEARO @WHOWPRO
RT @epivec: #Primaquine for preventing #Plasmodium #vivax relapses @jcu @AITropHealthMed @CPHMVS_JCU @WHOSEARO @WHOWPRO
#Primaquine for preventing #Plasmodium #vivax relapses @jcu @AITropHealthMed @CPHMVS_JCU @WHOSEARO @WHOWPRO
@jcu @AITropHealthMed @CPHMVS_JCU Primaquine for preventing P.vivax recurrences
RT @Cochrane_IDG: Updated @Cochrane_IDG Review: shorter, higher-dose #primaquine course (7 days at 0.5 mg/kg/day) as effective as standard…
Updated @Cochrane_IDG Review: shorter, higher-dose #primaquine course (7 days at 0.5 mg/kg/day) as effective as standard 0.25 mg/kg 14-day course for preventing recurrence in P. vivax #malaria, in people without G6PD deficiency. May promote adherence. http
RT @Cochrane_IDG: .@Cochrane_IDG Cochrane Review Update published today: #Primaquine alternative dosing schedules for preventing #malaria r…
.@Cochrane_IDG Cochrane Review Update published today: #Primaquine alternative dosing schedules for preventing #malaria relapse in people with #Plasmodium vivax. Access the full-text open access article here: https://t.co/N2dZc2ajUg